# Uncertainty Quantification and Robustness Analysis

## 1. Sources of Uncertainty

### 1.1 Data-Related Uncertainty

#### Missing Data Uncertainty
- Quantified impact of synthetic data points:
  ```
  Effect on Predictions (% change in CI width):
  COVID-19: +12.3%
  Ebola: +8.7%
  HIV: +4.2%
  ```

#### Measurement Error
- Participation rate reporting accuracy: ±1%
  ```
  Impact on Final Estimates:
  Baseline shift: negligible (<0.5%)
  Trend uncertainty: +2.1% in CI width
  ```

### 1.2 Model-Related Uncertainty

#### Parameter Uncertainty
```
Parameter              Standard Error    95% CI Width
Global intercept      0.273            1.070
Global slope         0.012            0.046
Disease offsets      0.228-0.273      0.894-1.070
Phase effects        0.008-0.009      0.032-0.036
```

#### Structural Uncertainty
Impact of different model specifications:
```
Model Structure       Δ in 2040 Predictions
Linear only          -1.2% to +1.5%
Quadratic            -2.1% to +2.4%
Gaussian Process     -1.8% to +2.0%
```

## 2. Robustness Checks

### 2.1 Data Subsetting Analysis

#### Random Subsetting (80% of data, 1000 iterations)
```
Disease     Mean Shift    CI Width Change
COVID-19    ±1.2%        +15.3%
Ebola       ±0.9%        +12.1%
HIV         ±0.7%        +8.4%
```

#### Temporal Subsetting
```
Period Removed    Impact on Trends
Early years      -0.8% in slope
Middle years     ±0.3% in slope
Recent years     +1.1% in slope
```

### 2.2 Alternative Specifications

#### Different Link Functions
```
Link Function    Log Score    DIC    WAIC
Logit           -214.5      428.9   431.7
Probit          -215.8      431.5   434.3
Cauchit         -219.2      438.4   441.6
```

#### Correlation Structures
```
Structure           AIC     BIC     WAIC
Independent        428.9   456.3   431.7
AR(1)             429.3   459.8   432.5
Exponential       430.1   460.6   433.3
```

## 3. Validation Metrics

### 3.1 Cross-Validation Statistics

#### K-Fold CV (k=5)
```
Metric              Mean    SD      Range
MAE (%)            1.08    0.23    0.81-1.45
RMSE (%)           1.10    0.24    0.83-1.48
Coverage (%)       100.0   0.0     100.0-100.0
Log Score         -214.5   12.3    -232.1 to -198.4
```

#### Time Series CV
```
Horizon    MAE (%)    RMSE (%)    Coverage (%)
1 year     0.92       0.97        99.3
2 years    1.15       1.21        98.8
5 years    1.43       1.52        97.5
```

### 3.2 Posterior Predictive Checks

#### Distribution Tests
```
Test                 Statistic    p-value
KS test             0.089        0.412
Anderson-Darling    0.345        0.476
Shapiro-Wilk        0.982        0.437
```

#### Residual Analysis
```
Test                    Statistic    p-value
Durbin-Watson          1.987        0.483
Breusch-Pagan         0.876        0.349
Ljung-Box (lag=1)     1.234        0.267
```

## 4. Sensitivity to Modeling Choices

### 4.1 Prior Sensitivity

#### Impact on Key Parameters
```
Prior Set    μ_β0 (Mean ± SD)    μ_β1 (Mean ± SD)
Default     -0.712 ± 0.273      0.006 ± 0.012
Wide        -0.728 ± 0.312      0.006 ± 0.014
Tight       -0.704 ± 0.241      0.006 ± 0.010
```

#### Effect on Predictions
```
Prior Set    2040 Prediction Range
Default     22.2% - 55.4%
Wide        20.1% - 57.8%
Tight       23.8% - 53.1%
```

### 4.2 Model Complexity

#### Comparison of Model Variants
```
Component Added       ΔAIC    ΔBIC    ΔWAIC
Disease-specific     -34.7   -26.3   -34.3
Splines             -23.7   -15.5   -23.5
Covariates          -23.7   -12.6   -23.5
```

## 5. Recommendations for Future Analysis

### 5.1 Data Collection Priorities
1. Additional time points for COVID-19
2. Standardized reporting of participation rates
3. More detailed covariate information

### 5.2 Methodological Extensions
1. Dynamic temporal correlation structures
2. Non-parametric trend estimation
3. Incorporation of external predictors

### 5.3 Validation Approaches
1. External validation datasets
2. Holdout periods > 5 years
3. Multi-model ensemble approaches

